Genetic Variation in the Vitamin D Receptor (VDR) and the Vitamin D–Binding Protein (GC) and Risk for Colorectal Cancer: Results from the Colon Cancer Family Registry

Epidemiologic evidence supports a role for vitamin D in colorectal cancer (CRC) risk. Variants in vitamin D–related genes might modify the association between vitamin D levels and CRC risk. In this analysis, we did a comprehensive evaluation of common variants in the vitamin D receptor (VDR) and the vitamin D–binding protein (GC; group-specific component) genes using a population-based case–unaffected sibling control design that included 1,750 sibships recruited into the Colon Cancer Family Registry. We also evaluated whether any associations differed by calcium supplement use, family history of CRC, or tumor characteristics. Heterogeneity by calcium and vitamin D intake was evaluated for a subset of 585 cases and 837 sibling controls who completed a detailed food frequency questionnaire. Age- and sex-adjusted associations were estimated using conditional logistic regression. Overall, we did not find evidence for an association between any single-nucleotide polymorphism (SNP) in VDR or GC and risk for CRC (range of unadjusted P values 0.01-0.98 for VDR and 0.07-0.95 for GC). None of these associations was significant after adjustment for multiple comparisons. We also found no evidence that calcium or vitamin D intake (food and supplement) from the food frequency questionnaire modified the association estimates between VDR and GC SNPs and CRC. We did observe associations between SNPs in GC and microsatellite unstable CRC, although these results should be confirmed in additional studies. Overall, our results do not provide evidence for a role of common genetic variants in VDR or GC in susceptibility to CRC. Cancer Epidemiol Biomarkers Prev; 19(2); 525–36

[1]  F. Clavel-Chapelon,et al.  Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  M. McCullough,et al.  Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. , 2009, Annual review of nutrition.

[3]  Sara Gandini,et al.  Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. , 2009, Carcinogenesis.

[4]  R. Bostick,et al.  Effects of Vitamin D and Calcium Supplementation on Markers of Apoptosis in Normal Colon Mucosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2009, Cancer Prevention Research.

[5]  J. Brisson,et al.  Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. , 2009, The American journal of clinical nutrition.

[6]  M. Inoue,et al.  Dietary calcium, vitamin D, and the risk of colorectal cancer. , 2008, The American journal of clinical nutrition.

[7]  A. Tenesa,et al.  Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding , 2008, International journal of cancer.

[8]  R. Elston,et al.  Association of vitamin D receptor gene variants, adiposity and colon cancer. , 2008, Carcinogenesis.

[9]  J. Norris,et al.  Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.

[10]  J. Chang-Claude,et al.  The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  Dalin Li,et al.  Snagger: A user-friendly program for incorporating additional information for tagSNP selection , 2008, BMC Bioinformatics.

[12]  M. Boehnke,et al.  So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. , 2007, American journal of human genetics.

[13]  R. Wolff,et al.  CDX2 VDR Polymorphism and Colorectal Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[14]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[15]  I. Roots,et al.  Vitamin D receptor haplotypes protect against development of colorectal cancer , 2007, European Journal of Clinical Pharmacology.

[16]  W. Willett,et al.  A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. , 2007, Journal of the National Cancer Institute.

[17]  M. Inoue,et al.  Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study , 2007, British Journal of Cancer.

[18]  M. Thun,et al.  Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study , 2007, Breast Cancer Research.

[19]  J. Nam,et al.  Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. , 2006, Cancer letters.

[20]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[21]  Maureen A. Murtaugh,et al.  Haplotype Analysis of Common Vitamin D Receptor Variants and Colon and Rectal Cancers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[22]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[23]  R. Kittles,et al.  Sequence variation within the 5′ regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk , 2005, The Prostate.

[24]  K. Gunderson,et al.  High-throughput SNP genotyping on universal bead arrays. , 2005, Mutation research.

[25]  J. Potter,et al.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.

[26]  Eric A. Miller,et al.  Calcium, Vitamin D, and Apoptosis in the Rectal Epithelium , 2005, Cancer Epidemiology Biomarkers & Prevention.

[27]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[28]  Yan Zhu,et al.  Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel disease , 2005 .

[29]  R. Wolff,et al.  Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States) , 2004, Cancer Causes & Control.

[30]  S. Neuhausen,et al.  Dietary calcium, vitamin D, VDR genotypes and colorectal cancer , 2004, International journal of cancer.

[31]  S. Hankinson,et al.  Plasma vitamin D metabolites and risk of colorectal cancer in women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  Timothy R Church,et al.  Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. , 2003, Journal of the National Cancer Institute.

[33]  M. Lipkin,et al.  Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms , 2003, Nature Reviews Cancer.

[34]  R. Bostick,et al.  Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use? , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  S. Ingles,et al.  Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. , 2003, Carcinogenesis.

[36]  M. Olivier A haplotype map of the human genome. , 2003, Nature.

[37]  M. Olivier A haplotype map of the human genome , 2003, Nature.

[38]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[39]  D. Alberts,et al.  Calcium, vitamin D, and risk of adenoma recurrence (United States) , 2002, Cancer Causes & Control.

[40]  R. Sinha,et al.  Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[42]  C. Ulrich,et al.  Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  A. G. de Herreros,et al.  Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling , 2001, The Journal of cell biology.

[44]  G. Coetzee,et al.  Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States) , 2001, Cancer Causes & Control.

[45]  S. Neuhausen,et al.  Variants of the VDR gene and Risk of Colon Cancer (United States) , 2001, Cancer Causes & Control.

[46]  B Langholz,et al.  Testing linkage disequilibrium in sibships. , 2000, American journal of human genetics.

[47]  J. Potter,et al.  Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States) , 2000, Cancer Causes & Control.

[48]  C. Paraskeva,et al.  Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.

[49]  D O Stram,et al.  Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. , 2000, American journal of epidemiology.

[50]  H. Iishi,et al.  Inhibition of angiogenesis as a mechanism for inhibition by Lα‐hydroxyvitamin D3 and 1,25‐dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats , 1999, International journal of cancer.

[51]  J. Witte,et al.  Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. , 1999, American journal of epidemiology.

[52]  P. Newcomb,et al.  The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. , 1998, International journal of epidemiology.

[53]  M. Haussler,et al.  The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  D. Albanes,et al.  Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men , 1997, Cancer Causes & Control.

[55]  J. Baron,et al.  Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  W. Willett,et al.  Calcium, vitamin D, and the occurrence of colorectal cancer among women. , 1996, Journal of the National Cancer Institute.

[57]  K. Helzlsouer,et al.  Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. , 1995, American journal of epidemiology.

[58]  T. Sellers,et al.  Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. , 1993, American journal of epidemiology.

[59]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[60]  C. Garland,et al.  SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY , 1989, The Lancet.

[61]  C. Garland,et al.  Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.

[62]  G. Currie,et al.  International Classification of Diseases for Oncology , 1977 .

[63]  K. Robien,et al.  the Iowa Women's Health Study , 2008 .

[64]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[65]  Cancer Epidemiol Biomarkers Prev , 2004 .

[66]  K. McGlynn,et al.  Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.